Why Rybelsus is included in MDL 3094
Rybelsus delivers semaglutide systemically, so it shares the same mechanism — and the same severe gastrointestinal effects — as injectable Ozempic. Plaintiffs taking Rybelsus are eligible to file in the consolidated federal litigation.
Qualifying injuries
Gastroparesis, severe pancreatitis, intestinal obstruction, gallbladder disease, vision loss (NAION), and aspiration during anesthesia are all qualifying injuries for Rybelsus users.